Is Metformin the Same as Semaglutide? A Clear Comparison

The biggest misconception: that both medicines are "just diabetes drugs" used off-label for weight

Plenty of people arrive at this question assuming that metformin and semaglutide are two versions of the same thing, perhaps because both have been discussed in the context of weight. The reality is more precise. Metformin has been prescribed for type 2 diabetes since the 1950s and its primary licensed use in the UK remains blood-sugar control in that condition. Any modest effect on body weight is a secondary consequence of better metabolic regulation, not the reason it is prescribed.

Semaglutide, by contrast, received its UK licence for weight management in its own right. Sold as Wegovy, it is a GLP-1 receptor agonist: it mimics a hormone released after eating, signals to the brain that you are full, and slows how quickly the stomach empties. The mechanism of semaglutide is specifically designed around appetite and energy intake, a fundamentally different target from metformin's action on the liver. NICE recommends semaglutide for weight management in eligible adults under its guidance TA875, which you can read directly on the NICE website. Metformin has no equivalent NICE recommendation for weight management.

So the short answer is no, they are not the same, and they are not interchangeable.

What semaglutide does that metformin does not

Semaglutide binds to GLP-1 receptors in the brain, gut and pancreas. The result is a meaningful reduction in appetite and food intake alongside slower gastric emptying. In the STEP 1 clinical trial, adults taking the 2.4 mg weekly dose over 68 weeks achieved an average body-weight reduction of around 15%, a figure reported in the New England Journal of Medicine. That scale of effect is not something metformin produces. Metformin's job is to help the liver behave more normally with respect to glucose, and to make cells respond better to insulin. It does not suppress appetite through a hormonal pathway.

There is also a practical difference in how these medicines are taken. Semaglutide as Wegovy is a once-weekly subcutaneous injection, a pre-filled pen that delivers the dose under the skin, typically starting at a lower dose and titrated upward by the prescriber over several months. Metformin is taken as a daily oral tablet. Some people who ask whether semaglutide and metformin are the same are actually wondering whether the injection can be avoided in favour of a tablet, and it is worth knowing that an oral form of semaglutide (Wegovy tablets) was approved by the MHRA in June 2026 for weight management, though it is a distinct product from metformin.

If you are curious about how Wegovy relates to the semaglutide brand name, that page covers the naming clearly.

Can you take metformin and semaglutide together?

This is a question our prescribers hear regularly, especially from people who already take metformin for type 2 diabetes and are considering adding a GLP-1 medicine for weight management. The two are not the same, but they are sometimes used alongside each other, always under prescriber supervision and as part of a broader clinical plan. Whether metformin and Wegovy can be taken together depends on your individual health circumstances, current doses and any other medicines you use.

It is also worth separating a related question: some people ask whether semaglutide is contained within metformin. It is not. They are chemically unrelated compounds. No combination product blending the two exists in the UK.

If you are taking metformin and considering a GLP-1 medicine, the right starting point is an honest conversation with a prescriber about your full medical history. At nume, a GPhC-registered prescriber reads every consultation personally, not an automated system. For a broader look at the options available, our weight-loss treatments overview sets out what is currently licensed in the UK. For context on what private treatment typically costs, this page on obtaining Wegovy through a UK pharmacy covers the process and pricing landscape.

Which medicine is right for weight management?

For adults in the UK seeking a medicine specifically licensed to support weight loss, metformin is not that medicine. Semaglutide as Wegovy is, as is tirzepatide (Mounjaro), a dual GIP and GLP-1 receptor agonist. Metformin may form part of a broader diabetes management plan where weight is also a concern, but it should not be sought out as a substitute for a licensed weight-management medicine.

The NHS page on semaglutide is a good plain-English reference for understanding what Wegovy does and its known side effects. Semaglutide is a prescription-only medicine: accessing it legally in the UK requires clinical assessment. At nume, once a prescriber approves your consultation, treatment is dispatched the same day and arrives the next working day via DPD in a plain, unbranded box, no indication on the outside of what is inside. If you would like a prescriber to review whether Wegovy is appropriate for you, the consultation is free and takes only a few minutes to start.